<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.0 20040830//EN" "journalpublishing.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="2.0" xml:lang="en" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">JMIR Form Res</journal-id><journal-id journal-id-type="publisher-id">formative</journal-id><journal-id journal-id-type="index">27</journal-id><journal-title>JMIR Formative Research</journal-title><abbrev-journal-title>JMIR Form Res</abbrev-journal-title><issn pub-type="epub">2561-326X</issn><publisher><publisher-name>JMIR Publications</publisher-name><publisher-loc>Toronto, Canada</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">v10i1e89464</article-id><article-id pub-id-type="doi">10.2196/89464</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Paper</subject></subj-group></article-categories><title-group><article-title>Real-World Implementation of EndoConnect in Brazilian Primary Care: Formative Study of Usability, Engagement, and Equity in Digital Endometriosis Care</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Luz</surname><given-names>Kelnner Portela</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ferreira Lima</surname><given-names>Danilo Lopes</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib></contrib-group><aff id="aff1"><institution>Department of Radiology, Hospital Geral de Fortaleza</institution><addr-line>Rua Riachuelo 900, Papicu</addr-line><addr-line>Fortaleza</addr-line><addr-line>Cear&#x00E1;</addr-line><country>Brazil</country></aff><aff id="aff2"><institution>Graduate Program in Health Education and Educational Technologies (MESTED), Unichristus</institution><addr-line>Fortaleza</addr-line><country>Brazil</country></aff><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Sarvestan</surname><given-names>Javad</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name name-style="western"><surname>Liang</surname><given-names>Xiaolong</given-names></name></contrib></contrib-group><author-notes><corresp>Correspondence to Kelnner Portela Luz, MD, Department of Radiology, Hospital Geral de Fortaleza, Rua Riachuelo 900, Papicu, Fortaleza, Cear&#x00E1;, 60150-160, Brazil, 55 34579261; <email>kelnnerportela@gmail.com</email></corresp></author-notes><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>27</day><month>5</month><year>2026</year></pub-date><volume>10</volume><elocation-id>e89464</elocation-id><history><date date-type="received"><day>12</day><month>12</month><year>2025</year></date><date date-type="rev-recd"><day>04</day><month>04</month><year>2026</year></date><date date-type="accepted"><day>04</day><month>04</month><year>2026</year></date></history><copyright-statement>&#x00A9; Kelnner Portela Luz, Danilo Lopes Ferreira Lima. Originally published in JMIR Formative Research (<ext-link ext-link-type="uri" xlink:href="https://formative.jmir.org">https://formative.jmir.org</ext-link>), 27.5.2026. </copyright-statement><copyright-year>2026</copyright-year><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Formative Research, is properly cited. The complete bibliographic information, a link to the original publication on <ext-link ext-link-type="uri" xlink:href="https://formative.jmir.org">https://formative.jmir.org</ext-link>, as well as this copyright and license information must be included.</p></license><self-uri xlink:type="simple" xlink:href="https://formative.jmir.org/2026/1/e89464"/><abstract><sec><title>Background</title><p>Endometriosis is a chronic gynecological condition affecting approximately 10% of women of reproductive age worldwide and is associated with chronic pelvic pain, infertility, and reduced quality of life. In Brazil&#x2019;s Unified Health System (Sistema &#x00DA;nico de Sa&#x00FA;de [SUS]), diagnostic delays frequently range from 7 to 10 years and disproportionately affect socially vulnerable populations, including rural, low-income, Black, and Indigenous women. Digital health interventions have been proposed as scalable solutions; however, most available applications are developed in high-income settings and do not align with the structural and operational realities of low- and middle-income countries (LMICs).</p></sec><sec><title>Objective</title><p>This study aimed to evaluate feasibility, usability, acceptability, and user engagement associated with the real-world implementation of EndoConnect Alpha in primary health care settings, and to explore preliminary patterns of change in symptom burden, knowledge, and care navigation.</p></sec><sec sec-type="methods"><title>Methods</title><p>A single-arm, prospective, formative implementation study was conducted in 10 primary health care units in Cear&#x00E1;, Brazil. A convenience sample of 60 participants, including women with suspected or confirmed endometriosis and primary care professionals, used the platform over an 8-week period under real-world conditions. Usability (assessed using the System Usability Scale), acceptability (assessed using the Technology Acceptance Model), engagement metrics, and exploratory outcomes were assessed. All analyses were exploratory, with no control group and no causal inference.</p></sec><sec sec-type="results"><title>Results</title><p>High usability and acceptability were observed, with strong user engagement, including a 79% completion rate of educational modules and consistent platform use. Observed decreases in pelvic pain and anxiety were identified, alongside increases in disease-related knowledge, self-reported therapy adherence, and reported gynecological referrals. A positive association between usability and acceptability was also observed. These findings should be interpreted as exploratory signals given the study design. Descriptive subgroup analyses suggested more pronounced trends among rural participants and those with a lower education level.</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>The real-world implementation of EndoConnect Alpha demonstrated high feasibility, usability, and acceptability within a public primary care setting in a middle-income country. Observed trends suggest potential benefits, particularly among underserved populations; however, causal inference cannot be established. These findings support further controlled evaluation and highlight the relevance of equity-oriented digital health strategies tailored to LMIC contexts.</p></sec></abstract><kwd-group><kwd>endometriosis</kwd><kwd>digital health</kwd><kwd>mHealth</kwd><kwd>primary health care</kwd><kwd>health equity</kwd><kwd>usability</kwd><kwd>implementation science</kwd><kwd>low- and middle-income countries</kwd></kwd-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Endometriosis is a chronic, estrogen-dependent inflammatory gynecological condition characterized by the presence of endometrial-like tissue outside the uterine cavity. It affects approximately 10% of women of reproductive age worldwide, corresponding to nearly 190 million individuals [<xref ref-type="bibr" rid="ref1">1</xref>-<xref ref-type="bibr" rid="ref3">3</xref>]. The disease is associated with chronic pelvic pain, dysmenorrhea, dyspareunia, infertility, and substantial psychosocial burden, leading to significant impairment in quality of life and economic productivity [<xref ref-type="bibr" rid="ref4">4</xref>].</p><p>Despite its high prevalence, diagnostic delay remains a major global challenge, typically ranging from 7 to 10 years and frequently extending beyond a decade in low- and middle-income countries (LMICs) [<xref ref-type="bibr" rid="ref2">2</xref>]. In Brazil, where the Unified Health System (Sistema &#x00DA;nico de Sa&#x00FA;de [SUS]) serves as the primary entry point for care, these delays are further compounded by structural barriers in primary health care, including limited professional training, restricted access to diagnostic pathways, and the absence of standardized patient-facing educational tools [<xref ref-type="bibr" rid="ref5">5</xref>,<xref ref-type="bibr" rid="ref6">6</xref>]. These constraints disproportionately affect rural, low-income, Black, and Indigenous populations, reinforcing persistent inequities in women&#x2019;s health.</p><p>Digital health interventions have emerged as scalable strategies to support patient education, symptom monitoring, and care navigation in chronic conditions [<xref ref-type="bibr" rid="ref7">7</xref>-<xref ref-type="bibr" rid="ref9">9</xref>]. However, most existing endometriosis-related applications have been developed in high-income settings and rely on assumptions that do not reflect LMIC realities, such as continuous internet access, high digital literacy, and relatively homogeneous user populations [<xref ref-type="bibr" rid="ref8">8</xref>,<xref ref-type="bibr" rid="ref9">9</xref>]. Broader evidence on digital health implementation highlights the importance of contextual adaptation, usability, and health system integration to ensure effectiveness in real-world settings [<xref ref-type="bibr" rid="ref7">7</xref>-<xref ref-type="bibr" rid="ref10">10</xref>]. Recent evaluations of mobile health (mHealth) applications for endometriosis care highlight variability in quality and clinical utility.</p><p>In parallel, advances in artificial intelligence (AI) have introduced new possibilities for clinical decision support, patient education, and diagnostic pathways in health care [<xref ref-type="bibr" rid="ref11">11</xref>-<xref ref-type="bibr" rid="ref14">14</xref>]. Nevertheless, significant challenges remain regarding transparency, bias, accountability, and equitable deployment, particularly in resource-constrained environments [<xref ref-type="bibr" rid="ref4">4</xref>,<xref ref-type="bibr" rid="ref11">11</xref>-<xref ref-type="bibr" rid="ref14">14</xref>]. These concerns are especially relevant in women&#x2019;s health and endometriosis care, where disparities in access, diagnosis, and treatment are well documented.</p><p>Recent international guidance, including recommendations from the World Health Organization and broader frameworks on responsible AI in health, emphasizes the need to incorporate equity, transparency, and data governance into digital health solutions [<xref ref-type="bibr" rid="ref4">4</xref>,<xref ref-type="bibr" rid="ref10">10</xref>]. Despite these advances, there remains a lack of empirically grounded examples of digital platforms specifically designed and implemented within public health systems in LMIC contexts.</p><p>EndoConnect Alpha was developed to address this gap as an offline-capable digital platform tailored to the operational realities of SUS primary care. The platform integrates structured educational content, symptom tracking, community support, and care navigation resources, with architectural preparation for future responsible AI integration.</p><p>The state of Cear&#x00E1; was selected as the implementation setting due to its socioeconomic heterogeneity and limited access to specialized gynecological care, providing a relevant context for evaluating equity-oriented digital health strategies.</p><p>This study aimed to evaluate the real-world implementation of EndoConnect Alpha in primary care settings by assessing feasibility, usability, acceptability, and user engagement, exploring patterns of change in symptom burden, knowledge, and care navigation, and describing implementation-informed considerations for ethical governance of digital health tools in LMIC contexts.</p></sec><sec id="s2" sec-type="methods"><title>Methods</title><sec id="s2-1"><title>Study Design</title><p>This study was designed as a single-arm, prospective, formative implementation study to evaluate the real-world deployment of the EndoConnect Alpha platform in primary health care settings. The study focused on feasibility, usability, acceptability, engagement, and exploratory signals of change, rather than hypothesis testing or causal inference. This approach is consistent with early-stage evaluations commonly used in digital health and mHealth implementation research [<xref ref-type="bibr" rid="ref7">7</xref>-<xref ref-type="bibr" rid="ref9">9</xref>].</p></sec><sec id="s2-2"><title>Setting</title><p>The study was conducted across 10 primary health care units within the Brazilian Unified Health System (SUS) in the state of Cear&#x00E1;, Brazil. The SUS serves as the primary entry point to health care for the majority of the population and is guided by national digital health strategies aimed at expanding access and improving care coordination [<xref ref-type="bibr" rid="ref5">5</xref>,<xref ref-type="bibr" rid="ref6">6</xref>].</p><p>The selected units included both urban and rural settings, reflecting heterogeneous socioeconomic conditions and varying levels of internet connectivity, which are characteristic of health systems in middle-income countries.</p></sec><sec id="s2-3"><title>Participants</title><p>A convenience sample of participants was recruited between January 2024 and November 2025 through local primary health care units under real-world conditions. Eligibility criteria are summarized in <xref ref-type="table" rid="table1">Table 1</xref>.</p><table-wrap id="t1" position="float"><label>Table 1.</label><caption><p>Eligibility criteria for study participants.</p></caption><table id="table1" frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom">Participant group</td><td align="left" valign="bottom">Inclusion criteria</td><td align="left" valign="bottom">Exclusion criteria</td></tr></thead><tbody><tr><td align="left" valign="top">Women</td><td align="left" valign="top">Age between 18 and 45 years; suspected or confirmed diagnosis of endometriosis; access to a smartphone compatible with the platform</td><td align="left" valign="top">Inability to provide informed consent; inability to interact with the application interface</td></tr><tr><td align="left" valign="top">Health professionals</td><td align="left" valign="top">Active practice in primary health care; involvement in women&#x2019;s health care</td><td align="left" valign="top">Inability to provide informed consent; inability to interact with the application interface</td></tr></tbody></table></table-wrap></sec><sec id="s2-4"><title>Intervention</title><p>EndoConnect Alpha is an offline-capable progressive web application designed to support endometriosis education, symptom tracking, and care navigation within primary health care.</p><p>The platform integrates five core components: evidence-based educational modules adapted for low literacy, a symptom diary with longitudinal tracking, a moderated peer-support environment, guidance on public health system care pathways, and privacy-preserving infrastructure designed for future AI integration. The platform was developed with an offline-first architecture, enabling full functionality without continuous internet connectivity and deferring synchronization until network access is restored.</p><p>Participants were encouraged to use the platform over an 8-week period, without predefined usage frequency, allowing naturalistic interaction patterns.</p><p>This design approach is consistent with recommendations for digital health interventions in resource-constrained settings [<xref ref-type="bibr" rid="ref9">9</xref>,<xref ref-type="bibr" rid="ref10">10</xref>].</p><p>An overview of the educational modules and platform structure is provided in <xref ref-type="table" rid="table2">Table 2</xref>.</p><table-wrap id="t2" position="float"><label>Table 2.</label><caption><p>Overview of educational modules and platform structure.</p></caption><table id="table2" frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom">Module</td><td align="left" valign="bottom">Content focus</td><td align="left" valign="bottom">Format</td><td align="left" valign="bottom">Objective</td></tr></thead><tbody><tr><td align="left" valign="top">Module 1</td><td align="left" valign="top">Understanding endometriosis (symptoms, pathophysiology, and diagnosis)</td><td align="left" valign="top">Text+visual illustrations</td><td align="left" valign="top">Improve basic disease knowledge and symptom recognition</td></tr><tr><td align="left" valign="top">Module 2</td><td align="left" valign="top">Pain management and self-care strategies</td><td align="left" valign="top">Text+practical guidance</td><td align="left" valign="top">Support symptom management and daily functioning</td></tr><tr><td align="left" valign="top">Module 3</td><td align="left" valign="top">Mental health and emotional support</td><td align="left" valign="top">Text+reflective prompts</td><td align="left" valign="top">Address anxiety, emotional burden, and coping strategies</td></tr><tr><td align="left" valign="top">Module 4</td><td align="left" valign="top">Navigating the public health system (SUS<sup><xref ref-type="table-fn" rid="table2fn1">a</xref></sup>)</td><td align="left" valign="top">Step-by-step guidance</td><td align="left" valign="top">Facilitate access to care pathways and referrals</td></tr><tr><td align="left" valign="top">Module 5</td><td align="left" valign="top">Community and peer support</td><td align="left" valign="top">Moderated forum</td><td align="left" valign="top">Promote shared experiences and reduce isolation</td></tr></tbody></table><table-wrap-foot><fn id="table2fn1"><p><sup>a</sup>SUS: Sistema &#x00DA;nico de Sa&#x00FA;de.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s2-5"><title>Outcomes</title><p>The study evaluated four domains: usability, acceptability, engagement, and exploratory outcomes related to symptom experience and care navigation. Usability was measured using the System Usability Scale, a validated instrument for assessing perceived usability in digital systems [<xref ref-type="bibr" rid="ref8">8</xref>]. Acceptability was assessed through constructs derived from the Technology Acceptance Model (TAM), including perceived usefulness and ease of use [<xref ref-type="bibr" rid="ref9">9</xref>]. Engagement was captured through application analytics, including frequency of use, session duration, and completion of educational modules. Exploratory outcomes included pelvic pain assessed using the Visual Analog Scale, disease-related knowledge assessed using the EKES-15 (Endometriosis Knowledge and Education Scale) questionnaire, anxiety symptoms measured with the Generalized Anxiety Disorder-7 Scale, self-reported therapy adherence, and reported gynecological referral occurrence. These outcomes were interpreted cautiously, given the absence of a control group.</p></sec><sec id="s2-6"><title>Data Collection</title><p>Data were collected using in-app analytics (Firebase), self-reported questionnaires, and baseline and postintervention assessments conducted over an 8-week period. All data were anonymized at the point of collection and stored securely.</p></sec><sec id="s2-7"><title>Statistical Analysis</title><p>Statistical analyses were conducted using descriptive and exploratory methods appropriate for formative studies. Continuous variables were expressed as mean and SD, paired comparisons were performed where applicable, and correlations were assessed using the Spearman coefficient. To explore potential relationships between engagement and outcomes, correlation analyses were conducted. All analyses were considered exploratory and were not powered for causal inference. No correction for multiple comparisons was applied, and findings should be interpreted as hypothesis-generating [<xref ref-type="bibr" rid="ref7">7</xref>-<xref ref-type="bibr" rid="ref9">9</xref>]. A significance level of &#x03B1;=.05 was adopted. Statistical analyses were performed using IBM SPSS Statistics (version 25.0).</p></sec><sec id="s2-8"><title>Missing Data</title><p>Missing data were handled using complete-case analysis, given the exploratory nature of the study. No imputation methods were applied. The potential impact of missing data is addressed in the Discussion (Limitations) section.</p></sec><sec id="s2-9"><title>Ethical Considerations</title><p>This study was approved by the Research Ethics Committee of Centro Universit&#x00E1;rio Christus (approval number 7.044.486; August 30, 2024) and conducted in accordance with the principles of the Declaration of Helsinki [<xref ref-type="bibr" rid="ref15">15</xref>] and applicable Brazilian regulations governing research involving human subjects, including the General Data Protection Law (Lei Geral de Prote&#x00E7;&#x00E3;o de Dados; Law No. 13.709/2018) [<xref ref-type="bibr" rid="ref16">16</xref>] and the National Health Council Resolution (No. 466/2012) [<xref ref-type="bibr" rid="ref17">17</xref>].</p><p>All participants provided informed consent prior to inclusion. To ensure accessibility, an audio-assisted consent option was made available for individuals with lower literacy levels. Participation was voluntary, and no identifiable personal data were collected.</p><p>Data were anonymized at the point of collection and stored in secure, encrypted environments with restricted access controls. Authentication procedures were implemented to ensure data integrity and prevent unauthorized access.</p><p>The platform architecture incorporated design elements aligned with principles of responsible digital health and AI governance, including data minimization, auditability, and user-controlled consent mechanisms in accordance with international recommendations for ethical and equitable digital health systems [<xref ref-type="bibr" rid="ref4">4</xref>,<xref ref-type="bibr" rid="ref10">10</xref>]. No active AI models were deployed or evaluated during the study period.</p></sec></sec><sec id="s3" sec-type="results"><title>Results</title><sec id="s3-1"><title>Participant Characteristics</title><p>Among women, the mean age was 32.4 (SD 5.7, range 19-44) years. Educational attainment varied: 72% of participants had higher education, 20% of participants had secondary education, and 8% of participants had only primary education. A substantial proportion reported chronic symptom burden, including pelvic pain lasting more than 12 months (68%), severe dysmenorrhea (62%), deep dyspareunia (44%), and concerns about infertility (34%). Psychosocial burden was notable, with 64% reporting reduced work or study productivity and 58% reporting social interference.</p><p>Self-reported race/color (Brazilian Institute of Geography and Statistics classification) were Black or Brown (preta/parda) among 42% of participants and White among 50% of participants, and 8% of participants were Indigenous or belonged to other racial or ethnic communities. The Socioeconomic classification (Crit&#x00E9;rio Brasil) [<xref ref-type="bibr" rid="ref18">18</xref>] indicated that 55% of participants belonged to classes C, D, or E. Regarding technology access, 82% reported exclusive smartphone use, and 70% reported high familiarity with health-related applications.</p><p>Primary care professionals had a mean age of 36.2 (SD 7.1) years, with 80% identifying as female. Professional roles included family physicians (47%), nurses (33%), and pelvic physiotherapists (20%), with 60% reporting more than 5 years of experience in primary care. At baseline, 93% reported difficulty accessing endometriosis-related clinical protocols, 73% reported a lack of patient-facing educational materials, and 60% reported low confidence in symptom identification.</p><p>The participant recruitment process is presented in <xref ref-type="fig" rid="figure1">Figure 1</xref>. Weekly engagement patterns are summarized in <xref ref-type="table" rid="table3">Table 3</xref>.</p><fig position="float" id="figure1"><label>Figure 1.</label><caption><p>Participant recruitment flow diagram. SUS: Sistema &#x00DA;nico de Sa&#x00FA;de.</p></caption><graphic alt-version="no" mimetype="image" position="float" xlink:type="simple" xlink:href="formative_v10i1e89464_fig01.png"/></fig><table-wrap id="t3" position="float"><label>Table 3.</label><caption><p>Weekly engagement metrics for EndoConnect Alpha.</p></caption><table id="table3" frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom">Week</td><td align="left" valign="bottom">Active users, %</td><td align="left" valign="bottom">Mean daily use (min), mean (SD)</td><td align="left" valign="bottom">Forum posts (average per user), mean</td><td align="left" valign="bottom">Trail completion, %</td></tr></thead><tbody><tr><td align="left" valign="top">1</td><td align="left" valign="top">92</td><td align="left" valign="top">19.5 (7.1)</td><td align="left" valign="top">1.8</td><td align="left" valign="top">44</td></tr><tr><td align="left" valign="top">2</td><td align="left" valign="top">88</td><td align="left" valign="top">18.3 (6.8)</td><td align="left" valign="top">2.4</td><td align="left" valign="top">62</td></tr><tr><td align="left" valign="top">3</td><td align="left" valign="top">85</td><td align="left" valign="top">17.9 (6.5)</td><td align="left" valign="top">2.7</td><td align="left" valign="top">71</td></tr><tr><td align="left" valign="top">4</td><td align="left" valign="top">84</td><td align="left" valign="top">17.2 (6.3)</td><td align="left" valign="top">2.9</td><td align="left" valign="top">76</td></tr><tr><td align="left" valign="top">5&#x2010;8</td><td align="left" valign="top">81</td><td align="left" valign="top">16.8 (6.0)</td><td align="left" valign="top">3.1</td><td align="left" valign="top">79<sup><xref ref-type="table-fn" rid="table3fn1">a</xref></sup></td></tr></tbody></table><table-wrap-foot><fn id="table3fn1"><p><sup>a</sup>Final value.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3-2"><title>Usability and Acceptability</title><p>High usability was observed, with a mean System Usability Scale score of 88.9 (SD 9.8), corresponding to an &#x201C;excellent&#x201D; rating according to established benchmarks [<xref ref-type="bibr" rid="ref8">8</xref>]. Professionals presented higher usability scores than patients (mean 92.3, SD 8.1 vs mean 87.4, SD 10.2; <italic>P</italic>=.04).</p><p>Acceptability was also high, with a global TAM score of 91.4%, including perceived usefulness of 4.6 out of 5 and ease of use of 4.5 out of 5, consistent with established technology adoption constructs [<xref ref-type="bibr" rid="ref9">9</xref>]. A strong correlation between usability and acceptability was identified (Spearman &#x03C1;=0.76; <italic>P</italic>&#x003C;.001).</p><p>Digital literacy and educational level were associated with variability in usability scores. These observations are descriptive, exploratory, and should be interpreted cautiously.</p><p>Subgroup differences in usability and acceptability scores are illustrated in <xref ref-type="fig" rid="figure2">Figure 2</xref>.</p><fig position="float" id="figure2"><label>Figure 2.</label><caption><p>Mediated pathway model.</p></caption><graphic alt-version="no" mimetype="image" position="float" xlink:type="simple" xlink:href="formative_v10i1e89464_fig02.png"/></fig></sec><sec id="s3-3"><title>Engagement Metrics</title><p>User engagement was high throughout the study period. Educational module completion reached 79%, and mean daily platform use was 17.2 (SD 6.3) minutes. Forum participation occurred in 67% of users, with an average of 2.3 posts per participant. Clinical and psychosocial outcomes across subgroups are presented in <xref ref-type="table" rid="table4">Table 4</xref>.</p><table-wrap id="t4" position="float"><label>Table 4.</label><caption><p>Clinical and psychosocial outcomes by subgroup.</p></caption><table id="table4" frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom">Outcome</td><td align="left" valign="bottom">Overall (n=60)</td><td align="left" valign="bottom">Rural (n=36)</td><td align="left" valign="bottom">Urban (n=24)</td><td align="left" valign="bottom">Black/Brown/Indigenous (n=25)</td><td align="left" valign="bottom">White (n=35)</td><td align="left" valign="bottom"><italic>P</italic> value for interaction</td></tr></thead><tbody><tr><td align="left" valign="top">&#x0394; Pain VAS<sup><xref ref-type="table-fn" rid="table4fn1">a</xref></sup> (points)</td><td align="left" valign="top">&#x2013;1.7</td><td align="left" valign="top">&#x2013;1.9</td><td align="left" valign="top">&#x2013;1.4</td><td align="left" valign="top">&#x2013;2.0</td><td align="left" valign="top">&#x2013;1.4</td><td align="left" valign="top">.05</td></tr><tr><td align="left" valign="top">&#x0394; Anxiety (GAD-7<sup><xref ref-type="table-fn" rid="table4fn2">b</xref></sup>)</td><td align="left" valign="top">&#x2013;1.6</td><td align="left" valign="top">&#x2013;2.1</td><td align="left" valign="top">&#x2013;0.9</td><td align="left" valign="top">&#x2013;2.3</td><td align="left" valign="top">&#x2013;1.1</td><td align="left" valign="top">.04</td></tr><tr><td align="left" valign="top">&#x0394; Knowledge (EKES-15<sup><xref ref-type="table-fn" rid="table4fn3">c</xref></sup>)</td><td align="left" valign="top">+4.2</td><td align="left" valign="top">+4.8</td><td align="left" valign="top">+3.4</td><td align="left" valign="top">+5.1</td><td align="left" valign="top">+3.6</td><td align="left" valign="top">.02</td></tr><tr><td align="left" valign="top">Referral increase (%)</td><td align="left" valign="top">+15</td><td align="left" valign="top">&#x2014;<sup><xref ref-type="table-fn" rid="table4fn4">d</xref></sup></td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2014;</td></tr></tbody></table><table-wrap-foot><fn id="table4fn1"><p><sup>a</sup>VAS: Visual Analog Scale.</p></fn><fn id="table4fn2"><p><sup>b</sup>GAD-7: Generalized Anxiety Disorder-7 Scale.</p></fn><fn id="table4fn3"><p><sup>c</sup>EKES-15: Endometriosis Knowledge and Education Scale.</p></fn><fn id="table4fn4"><p><sup>d</sup>Not applicable.</p></fn></table-wrap-foot></table-wrap><p>A correlation analysis was conducted to explore the relationship between total platform use time and pelvic pain scores, showing a positive association (Spearman &#x03C1;=0.69; <italic>P</italic>&#x003C;.001). This finding is exploratory and should not be interpreted as evidence of a causal relationship.</p></sec><sec id="s3-4"><title>Exploratory Clinical and Psychosocial Outcomes</title><p>Over the 8-week observation period, several changes were observed across patient-reported and care-related outcomes. Decreases in pelvic pain and anxiety were identified, alongside increases in disease-related knowledge, self-reported therapy adherence, and reported gynecological referrals. These findings should be interpreted as exploratory signals of change, given the absence of a control group and the noncausal study design. Descriptive subgroup analyses suggested that trends were more pronounced among rural participants, individuals with lower educational attainment, and Black/Brown/Indigenous participants. These observations are exploratory and hypothesis-generating.</p><p>The relationships between platform use, knowledge acquisition, adherence, and pain reduction are illustrated in <xref ref-type="fig" rid="figure2">Figure 2</xref>.</p></sec><sec id="s3-5"><title>Exploratory Pathway Analysis</title><p>To explore potential relationships between engagement and outcomes, an exploratory pathway analysis was conducted using bootstrapping methods.</p><p>The analysis indicated a possible association between platform use frequency and variation in outcomes, involving intermediate variables such as knowledge acquisition and adherence.</p><p>Given the sample size and study design, these findings should be interpreted cautiously and considered hypothesis-generating rather than confirmatory.</p></sec><sec id="s3-6"><title>User-Reported Feedback</title><p>Five recurrent themes were identified, including validation of symptoms and reframing of pain perception, increased confidence in navigating the health system, perceived benefit of peer support, offline functionality as a key usability feature, and requests for greater representational diversity. Representative user statements are presented below.</p><disp-quote><p>For the first time, someone explains that my pain is not &#x2018;being dramatic&#x2019; or &#x2018;just part of being a woman.&#x2019;</p></disp-quote><disp-quote><p>Now I know exactly whom to see, what to ask for, and what my rights are within the SUS.</p></disp-quote><disp-quote><p>The forum saved me on crisis days &#x2013; I no longer feel completely alone with this disease.</p></disp-quote><disp-quote><p>I live in the rural interior with almost no signal &#x2013; the offline mode was essential for me.</p></disp-quote><disp-quote><p>There is a lack of images and examples of Black and Indigenous women in the ultrasound illustrations.</p></disp-quote><p>These observations represent descriptive user feedback and should be interpreted cautiously, as no formal qualitative methodology was applied.</p><p>A significant dose-response relationship was identified between average daily platform engagement and reduction in pelvic pain (measured using the Visual Analog Scale), with higher usage associated with greater symptom improvement (<italic>r</italic>= 0.69; <italic>P</italic>&#x003C;.001), as show in <xref ref-type="fig" rid="figure3">Figure 3</xref>.</p><fig position="float" id="figure3"><label>Figure 3.</label><caption><p>Dose&#x2013;response relationship between platform use and change in pelvic pain (measured using the Visual Analog Scale) in the EndoConnect Alpha study (n=60). Each point represents an individual participant. The solid line indicates the linear regression fit, and the shaded area represents the 95% CI. Greater average daily platform use (minutes/day) was significantly associated with greater reduction in pelvic pain (<italic>r</italic>=0.69; <italic>P</italic>&#x003C;.001).</p></caption><graphic alt-version="no" mimetype="image" position="float" xlink:type="simple" xlink:href="formative_v10i1e89464_fig03.png"/></fig></sec></sec><sec id="s4" sec-type="discussion"><title>Discussion</title><sec id="s4-1"><title>Principal Findings</title><p>This study describes the real-world implementation of an offline-capable digital health platform for endometriosis within primary care settings in a middle-income country. The findings indicate high usability (System Usability Scale score=88.9), strong acceptability (TAM score=91.4%), and sustained user engagement over the study period.</p><p>Exploratory analyses identified observed improvements in symptom burden, disease-related knowledge, self-reported adherence, and care navigation indicators. These findings should be interpreted cautiously, as the study design does not allow causal inference. Nevertheless, they provide initial signals of potential benefit under real-world conditions, consistent with prior mHealth and app-based studies in women&#x2019;s health and endometriosis [<xref ref-type="bibr" rid="ref7">7</xref>-<xref ref-type="bibr" rid="ref9">9</xref>,<xref ref-type="bibr" rid="ref19">19</xref>].</p></sec><sec id="s4-2"><title>Relationship With Prior Work and Design Foundations</title><p>These findings build upon a previously described user-centered design and development process, in which EndoConnect was engineered to address structural constraints of public health systems, including limited connectivity, heterogeneous digital literacy, and the need for ethical preparedness for future AI integration.</p><p>The alignment between design features&#x2014;such as offline functionality, multimodal content delivery, and simplified navigation&#x2014;and observed engagement patterns is consistent with evidence that context-adapted digital health interventions are more likely to be adopted and sustained in LMIC settings [<xref ref-type="bibr" rid="ref7">7</xref>-<xref ref-type="bibr" rid="ref10">10</xref>].</p></sec><sec id="s4-3"><title>Equity-Oriented Interpretation</title><p>An important observation is the magnitude of trends identified among historically underserved populations, including rural participants, individuals with lower educational attainment, and Black/Brown/Indigenous users.</p><p>Although causal relationships cannot be established, these patterns suggest that equity-oriented design elements&#x2014;particularly offline-first architecture and accessible content&#x2014;may help reduce barriers to engagement in digital health. These findings are consistent with prior literature documenting disparities in endometriosis diagnosis, access to care, and outcomes across underserved populations [14,18].</p></sec><sec id="s4-4"><title>Interpretation of Engagement and Behavioral Patterns</title><p>The observed associations between platform use and outcome variation, as well as exploratory pathway analyses, suggest potential relationships among engagement, knowledge acquisition, and behavioral indicators such as adherence.</p><p>However, given the small sample size, the absence of a control group, and the exploratory analytical approach, these findings should be considered hypothesis-generating rather than indicative of underlying mechanisms. Similar exploratory patterns have been described in early-stage digital health evaluations, where engagement is associated with observed outcome variation [<xref ref-type="bibr" rid="ref7">7</xref>-<xref ref-type="bibr" rid="ref9">9</xref>,<xref ref-type="bibr" rid="ref19">19</xref>].</p></sec><sec id="s4-5"><title>Implications for Digital Health in LMIC Contexts</title><p>This study contributes to implementation-focused digital health research in LMICs by providing empirical evidence of feasibility and user engagement within a public health system.</p><p>Our findings reinforce the importance of architectures that are offline-capable, accessible across literacy levels, and aligned with existing care pathways and that incorporate ethical governance principles early. These elements are consistent with international recommendations for responsible digital health and AI deployment, emphasizing equity, transparency, and contextual adaptation [<xref ref-type="bibr" rid="ref4">4</xref>,<xref ref-type="bibr" rid="ref10">10</xref>].</p></sec><sec id="s4-6"><title>National Academy of Medicine&#x2013;Endora Framework (Implementation-Informed Perspective)</title><p>The NAM (National Academy of Medicine)-Endora Framework is presented as a conceptual synthesis derived from design decisions and implementation challenges observed during the development and deployment of the platform.</p><p>Rather than representing a purely theoretical construct, the framework reflects an attempt to operationalize key principles&#x2014;transparency, accountability, bias awareness, dynamic consent, and distributed data architectures&#x2014;within LMIC public health constraints.</p><p>For example, dynamic consent was operationalized through user-controlled permission settings within the platform, while accessibility and bias awareness were addressed through simplified content design and user feedback mechanisms. Auditability was supported by structured data handling and controlled access protocols embedded in the system architecture.</p><p>This perspective is consistent with emerging literature on AI-supported endometriosis care and diagnostic innovation [<xref ref-type="bibr" rid="ref11">11</xref>-<xref ref-type="bibr" rid="ref14">14</xref>]. The conceptual structure of the NAM-Endora Framework is illustrated in <xref ref-type="fig" rid="figure4">Figure 4</xref>.</p><p>A comparison between the NAM-Endora Framework and existing international guidelines is presented in <xref ref-type="table" rid="table5">Table 5</xref>.</p><p>This implementation-informed perspective may support future efforts to translate ethical AI guidance into practical digital health solutions.</p><fig position="float" id="figure4"><label>Figure 4.</label><caption><p>NAM-Endora framework. NAM: National Academy of Medicine.</p></caption><graphic alt-version="no" mimetype="image" position="float" xlink:type="simple" xlink:href="formative_v10i1e89464_fig04.png"/></fig><table-wrap id="t5" position="float"><label>Table 5.</label><caption><p>Comparison of the NAM<sup><xref ref-type="table-fn" rid="table5fn1">a</xref></sup>-Endora framework with existing guidelines.</p></caption><table id="table5" frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom">Feature</td><td align="left" valign="bottom">NAM-Endora (proposed 2025)</td><td align="left" valign="bottom">WHO<sup><xref ref-type="table-fn" rid="table5fn2">b</xref></sup> ethics (2021)</td><td align="left" valign="bottom">EU<sup><xref ref-type="table-fn" rid="table5fn3">c</xref></sup> AI<sup><xref ref-type="table-fn" rid="table5fn4">d</xref></sup> act (2024)</td><td align="left" valign="bottom">NAM code (2025)</td></tr></thead><tbody><tr><td align="left" valign="top">Explicit LMIC<sup><xref ref-type="table-fn" rid="table5fn5">e</xref></sup>/offline focus</td><td align="left" valign="top">Yes</td><td align="left" valign="top">Partial</td><td align="left" valign="top">No</td><td align="left" valign="top">Partial</td></tr><tr><td align="left" valign="top">Mandatory synthetic data for racial phenotypes</td><td align="left" valign="top">Yes</td><td align="left" valign="top">No</td><td align="left" valign="top">High-risk only</td><td align="left" valign="top">Recommended</td></tr><tr><td align="left" valign="top">Federated learning required</td><td align="left" valign="top">Yes</td><td align="left" valign="top">No</td><td align="left" valign="top">No</td><td align="left" valign="top">Encouraged</td></tr><tr><td align="left" valign="top">Dynamic consent implementation</td><td align="left" valign="top">Full granular UI<sup><xref ref-type="table-fn" rid="table5fn6">f</xref></sup></td><td align="left" valign="top">Recommended</td><td align="left" valign="top">Layered</td><td align="left" valign="top">Recommended</td></tr><tr><td align="left" valign="top">Community health agent integration</td><td align="left" valign="top">Yes</td><td align="left" valign="top">No</td><td align="left" valign="top">No</td><td align="left" valign="top">No</td></tr><tr><td align="left" valign="top">Bias testing in rural/low-literacy cohorts</td><td align="left" valign="top">Yes</td><td align="left" valign="top">No</td><td align="left" valign="top">No</td><td align="left" valign="top">Partial</td></tr></tbody></table><table-wrap-foot><fn id="table5fn1"><p><sup>a</sup>NAM: National Academy of Medicine.</p></fn><fn id="table5fn2"><p><sup>b</sup>WHO: World Health Organization.</p></fn><fn id="table5fn3"><p><sup>c</sup>EU: European Union.</p></fn><fn id="table5fn4"><p><sup>d</sup>AI: artificial intelligence.</p></fn><fn id="table5fn5"><p><sup>e</sup>LMIC: low- and middle-income country.</p></fn><fn id="table5fn6"><p><sup>f</sup>UI: user interface.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s4-7"><title>Limitations</title><p>This study has several limitations inherent to its formative design. The use of a convenience sample, the absence of a control group, and reliance on self-reported measures limit the ability to establish causal relationships between platform use and observed outcomes.</p><p>The sample size also restricts statistical power, particularly for subgroup and multivariable analyses, increasing the risk of type I error. Additionally, exploratory analyses&#x2014;including correlation and pathway modeling&#x2014;should be interpreted with caution.</p><p>Finally, the relatively short follow-up period does not allow assessment of long-term engagement or sustained clinical outcomes.</p></sec><sec id="s4-8"><title>Future Directions</title><p>Future research should prioritize controlled study designs, including randomized or quasi-experimental approaches, to evaluate causal relationships and long-term outcomes. Multicenter studies across diverse geographic and socioeconomic settings will be important to assess generalizability.</p><p>In addition, future work should examine how engagement patterns evolve over time and how digital interventions can be integrated into routine care pathways within public health systems.</p><p>Further investigation into integrating ethically governed AI capabilities within controlled, transparent frameworks may expand the platform&#x2019;s capabilities while maintaining equity, accountability, and data governance standards. Future implementations should also consider advances in AI-supported education and diagnostic pathways [<xref ref-type="bibr" rid="ref11">11</xref>-<xref ref-type="bibr" rid="ref14">14</xref>].</p></sec><sec id="s4-9"><title>Conclusions</title><p>The implementation of EndoConnect Alpha in real-world primary care settings demonstrated high feasibility, usability, and acceptability, with observed trends suggesting potential benefits in symptom experience, knowledge, and care navigation.</p><p>These findings provide formative evidence supporting the relevance of equity-oriented digital health strategies tailored to LMIC contexts. While confirmatory studies are required, the results highlight the potential of context-adapted digital interventions to address gaps in chronic disease management within public health systems.</p></sec></sec></body><back><ack><p>No active artificial intelligence models were deployed or evaluated during the study period.</p></ack><notes><sec><title>Funding</title><p>This study was conducted without external funding.</p></sec></notes><fn-group><fn fn-type="conflict"><p>None declared.</p></fn></fn-group><glossary><title>Abbreviations</title><def-list><def-item><term id="abb1">AI</term><def><p>artificial intelligence</p></def></def-item><def-item><term id="abb2">EKES-15</term><def><p>Endometriosis Knowledge and Education Scale</p></def></def-item><def-item><term id="abb3">LMIC</term><def><p>low- and middle-income country</p></def></def-item><def-item><term id="abb4">mHealth</term><def><p>mobile health</p></def></def-item><def-item><term id="abb5">NAM</term><def><p>National Academy of Medicine</p></def></def-item><def-item><term id="abb6">SUS</term><def><p>Sistema &#x00DA;nico de Sa&#x00FA;de</p></def></def-item><def-item><term id="abb7">TAM</term><def><p>Technology Acceptance Model</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="ref1"><label>1</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zondervan</surname><given-names>KT</given-names> </name><name name-style="western"><surname>Becker</surname><given-names>CM</given-names> </name><name name-style="western"><surname>Missmer</surname><given-names>SA</given-names> </name></person-group><article-title>Endometriosis</article-title><source>N Engl J Med</source><year>2020</year><month>03</month><day>26</day><volume>382</volume><issue>13</issue><fpage>1244</fpage><lpage>1256</lpage><pub-id pub-id-type="doi">10.1056/NEJMra1810764</pub-id><pub-id pub-id-type="medline">32212520</pub-id></nlm-citation></ref><ref id="ref2"><label>2</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Becker</surname><given-names>CM</given-names> </name><name name-style="western"><surname>Bokor</surname><given-names>A</given-names> </name><name name-style="western"><surname>Heikinheimo</surname><given-names>O</given-names> </name><etal/></person-group><article-title>ESHRE guideline: Endometriosis</article-title><source>Hum Reprod Open</source><year>2022</year><volume>2022</volume><issue>2</issue><fpage>hoac009</fpage><pub-id pub-id-type="doi">10.1093/hropen/hoac009</pub-id><pub-id pub-id-type="medline">35350465</pub-id></nlm-citation></ref><ref id="ref3"><label>3</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ioannidou</surname><given-names>A</given-names> </name><name name-style="western"><surname>Sakellariou</surname><given-names>M</given-names> </name><name name-style="western"><surname>Sarli</surname><given-names>V</given-names> </name><name name-style="western"><surname>Panagopoulos</surname><given-names>P</given-names> </name><name name-style="western"><surname>Machairiotis</surname><given-names>N</given-names> </name></person-group><article-title>New evidence about malignant transformation of endometriosis-a systematic review</article-title><source>J Clin Med</source><year>2025</year><month>04</month><day>25</day><volume>14</volume><issue>9</issue><fpage>2975</fpage><pub-id pub-id-type="doi">10.3390/jcm14092975</pub-id><pub-id pub-id-type="medline">40364006</pub-id></nlm-citation></ref><ref id="ref4"><label>4</label><nlm-citation citation-type="report"><article-title>Ethics and governance of artificial intelligence for health</article-title><year>2021</year><publisher-name>World Health Organization</publisher-name></nlm-citation></ref><ref id="ref5"><label>5</label><nlm-citation citation-type="book"><person-group person-group-type="author"><collab>Brasil</collab></person-group><article-title>Minist&#x00E9;rio da sa&#x00FA;de</article-title><source>Pol&#x00ED;tica Nacional de Aten&#x00E7;&#x00E3;o Integral &#x00E0; Sa&#x00FA;de Da Mulher</source><year>2020</year><publisher-name>Minist&#x00E9;rio da Sa&#x00FA;de</publisher-name></nlm-citation></ref><ref id="ref6"><label>6</label><nlm-citation citation-type="book"><person-group person-group-type="author"><collab>Brasil</collab></person-group><article-title>Minist&#x00E9;rio da sa&#x00FA;de</article-title><source>Estrat&#x00E9;gia de Sa&#x00FA;de Digital Para o Brasil 2020&#x2013;2028</source><year>2020</year><publisher-name>Minist&#x00E9;rio da Sa&#x00FA;de</publisher-name></nlm-citation></ref><ref id="ref7"><label>7</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Free</surname><given-names>C</given-names> </name><name name-style="western"><surname>Phillips</surname><given-names>G</given-names> </name><name name-style="western"><surname>Watson</surname><given-names>L</given-names> </name><etal/></person-group><article-title>The effectiveness of mobile-health technologies to improve health care service delivery processes: A systematic review and meta-analysis</article-title><source>PLoS Med</source><year>2013</year><volume>10</volume><issue>1</issue><fpage>e1001363</fpage><pub-id pub-id-type="doi">10.1371/journal.pmed.1001363</pub-id><pub-id pub-id-type="medline">23458994</pub-id></nlm-citation></ref><ref id="ref8"><label>8</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Agarwal</surname><given-names>S</given-names> </name><etal/></person-group><article-title>Evidence on feasibility and effective use of mHealth strategies by frontline health workers in developing countries: systematic review</article-title><source>Trop Med Int Health</source><year>2016</year><fpage>1003</fpage><lpage>1014</lpage><pub-id pub-id-type="doi">10.1111/tmi.12525</pub-id><pub-id pub-id-type="medline">25881735</pub-id></nlm-citation></ref><ref id="ref9"><label>9</label><nlm-citation citation-type="report"><article-title>Recommendations on digital interventions for health system strengthening</article-title><year>2019</year><publisher-name>World Health Organization</publisher-name></nlm-citation></ref><ref id="ref10"><label>10</label><nlm-citation citation-type="report"><article-title>Global strategy on digital health 2020&#x2013;2025</article-title><year>2020</year><publisher-name>World Health Organization</publisher-name></nlm-citation></ref><ref id="ref11"><label>11</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Topol</surname><given-names>EJ</given-names> </name></person-group><article-title>High-performance medicine: The convergence of human and artificial intelligence</article-title><source>Nat Med</source><year>2019</year><month>01</month><volume>25</volume><issue>1</issue><fpage>44</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1038/s41591-018-0300-7</pub-id><pub-id pub-id-type="medline">30617339</pub-id></nlm-citation></ref><ref id="ref12"><label>12</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Esteva</surname><given-names>A</given-names> </name><name name-style="western"><surname>Robicquet</surname><given-names>A</given-names> </name><name name-style="western"><surname>Ramsundar</surname><given-names>B</given-names> </name><etal/></person-group><article-title>A guide to deep learning in healthcare</article-title><source>Nat Med</source><year>2019</year><month>01</month><volume>25</volume><issue>1</issue><fpage>24</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1038/s41591-018-0316-z</pub-id><pub-id pub-id-type="medline">30617335</pub-id></nlm-citation></ref><ref id="ref13"><label>13</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kelly</surname><given-names>CJ</given-names> </name><etal/></person-group><article-title>Key challenges for delivering clinical impact with artificial intelligence</article-title><source>BMC Med</source><year>2019</year><volume>17</volume><fpage>195</fpage><pub-id pub-id-type="doi">10.1186/s12916-019-1426-2</pub-id><pub-id pub-id-type="medline">31665002</pub-id></nlm-citation></ref><ref id="ref14"><label>14</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shortliffe</surname><given-names>EH</given-names> </name><name name-style="western"><surname>Sep&#x00FA;lveda</surname><given-names>MJ</given-names> </name></person-group><article-title>Clinical decision support in the era of artificial intelligence</article-title><source>JAMA</source><year>2018</year><volume>320</volume><issue>21</issue><fpage>2199</fpage><lpage>2200</lpage><pub-id pub-id-type="doi">10.1001/jama.2018.17163</pub-id><pub-id pub-id-type="medline">30398550</pub-id></nlm-citation></ref><ref id="ref15"><label>15</label><nlm-citation citation-type="web"><article-title>WMA declaration of helsinki &#x2013; ethical principles for medical research involving human participants</article-title><source>World Medical Association</source><access-date>2026-05-26</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://www.wma.net/policies-post/wma-declaration-of-helsinki/">https://www.wma.net/policies-post/wma-declaration-of-helsinki/</ext-link></comment></nlm-citation></ref><ref id="ref16"><label>16</label><nlm-citation citation-type="web"><article-title>Brazilian General Data Protection Law (Lei Geral de Prote&#x00E7;&#x00E3;o de Dados &#x2013; Law No. 13.709/2018)</article-title><source>Presid&#x00EA;ncia da Rep&#x00FA;blica - Secretaria-Geral - Subchefia para Assuntos Jur&#x00ED;dicos</source><access-date>2026-05-26</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://www.planalto.gov.br/ccivil_03/_ato2015-2018/2018/lei/l13709.htm">https://www.planalto.gov.br/ccivil_03/_ato2015-2018/2018/lei/l13709.htm</ext-link></comment></nlm-citation></ref><ref id="ref17"><label>17</label><nlm-citation citation-type="web"><article-title>National health council resolution no. 466/2012</article-title><source>Minist&#x00E9;rio da Sa&#x00FA;de</source><access-date>2026-05-26</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://www.gov.br/conselho-nacional-de-saude/pt-br">https://www.gov.br/conselho-nacional-de-saude/pt-br</ext-link></comment></nlm-citation></ref><ref id="ref18"><label>18</label><nlm-citation citation-type="web"><article-title>Continuous PNAD - continuous national household sample survey</article-title><source>Instituto Brasileiro de Geografia e Estat&#x00ED;stica</source><access-date>2026-04-27</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://www.ibge.gov.br/en/statistics/social/population/18083-annual-dissemination-pnadc3.html">https://www.ibge.gov.br/en/statistics/social/population/18083-annual-dissemination-pnadc3.html</ext-link></comment></nlm-citation></ref><ref id="ref19"><label>19</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rohloff</surname><given-names>N</given-names> </name><name name-style="western"><surname>G&#x00F6;tz</surname><given-names>T</given-names> </name><name name-style="western"><surname>Kortekamp</surname><given-names>SS</given-names> </name><name name-style="western"><surname>Heinze</surname><given-names>NR</given-names> </name><name name-style="western"><surname>Weber</surname><given-names>C</given-names> </name><name name-style="western"><surname>Sch&#x00E4;fer</surname><given-names>SD</given-names> </name></person-group><article-title>Influence of app-based self-management on the quality of life of women with endometriosis</article-title><source>Cureus</source><year>2024</year><month>08</month><volume>16</volume><issue>8</issue><fpage>e67655</fpage><pub-id pub-id-type="doi">10.7759/cureus.67655</pub-id><pub-id pub-id-type="medline">39314601</pub-id></nlm-citation></ref></ref-list></back></article>